LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 76 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,554,000 | -6.8% | 890,700 | 0.0% | 0.12% | -7.5% |
| Q2 2021 | $3,812,000 | +0.9% | 890,700 | 0.0% | 0.13% | +4.7% |
| Q1 2021 | $3,777,000 | +9.3% | 890,700 | 0.0% | 0.13% | +15.3% |
| Q4 2020 | $3,456,000 | -3.7% | 890,700 | 0.0% | 0.11% | -10.5% |
| Q3 2020 | $3,590,000 | -5.4% | 890,700 | 0.0% | 0.12% | -25.7% |
| Q2 2020 | $3,794,000 | +1.4% | 890,700 | 0.0% | 0.17% | -34.5% |
| Q1 2020 | $3,741,000 | +22.8% | 890,700 | +14.9% | 0.26% | +48.3% |
| Q4 2019 | $3,046,000 | -55.3% | 775,000 | 0.0% | 0.17% | -65.2% |
| Q3 2019 | $6,820,000 | +28.2% | 775,000 | +34.8% | 0.49% | +8.1% |
| Q2 2019 | $5,319,000 | -33.2% | 575,000 | +115.0% | 0.46% | -46.2% |
| Q1 2018 | $7,966,000 | -7.5% | 267,500 | 0.0% | 0.85% | -46.0% |
| Q4 2017 | $8,608,000 | -7.5% | 267,500 | 0.0% | 1.57% | -25.7% |
| Q3 2017 | $9,304,000 | +16.8% | 267,500 | 0.0% | 2.12% | +11.8% |
| Q2 2017 | $7,963,000 | +59.4% | 267,500 | +59.8% | 1.89% | +73.4% |
| Q1 2017 | $4,997,000 | – | 167,400 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|